Related references
Note: Only part of the references are listed.Increase of vascular endothelial growth factor and interleukin-6 in the aqueous humour of patients with macular oedema and central retinal vein occlusion
Hidetaka Noma et al.
ACTA OPHTHALMOLOGICA (2010)
Changes of aqueous vascular endothelial growth factor and pigment epithelium-derived factor following intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion
Sung P. Park et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2009)
Vitreous Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Macular Edema with Central Retinal Vein Occlusion
Hidetaka Noma et al.
OPHTHALMOLOGY (2009)
Retinal Gene Expression and Muller Cell Responses after Branch Retinal Vein Occlusion in the Rat
Matus Rehak et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Ranibizumab for macular edema due to retinal vein occlusions: Implication of VEGF as a critical stimulator
Peter A. Campochiaro et al.
MOLECULAR THERAPY (2008)
Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion
H. Noma et al.
EYE (2008)
Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion
Sivakami A. Pai et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis
Sho-Ichi Yamagishi et al.
MICROVASCULAR RESEARCH (2006)
Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion
H Noma et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2006)
Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion - A short-term study
Diana Iturralde et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema
H Funatsu et al.
OPHTHALMOLOGY (2006)
Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6
H Noma et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Pigment-epithelium-derived factor is upregulated in photocoagulated human retinal pigment epithelial cells
LO Hattenbach et al.
OPHTHALMIC RESEARCH (2005)
Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site
H Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
PEDF derived from glial Muller cells: a possible regulator of retinal angiogenesis
W Eichler et al.
EXPERIMENTAL CELL RESEARCH (2004)
Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells
K Ohno-Matsui et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease
J Spranger et al.
DIABETES (2001)
Upregulation of pigment epithelium-derived factor after laser photocoagulation
N Ogata et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2001)
Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor
V Stellmach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Tomographic assessment of vitreous surgery for diabetic macular edema
T Otani et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2000)
Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1)
K Miyamoto et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
